Insulin‐like Growth Factor‐I Prevents Gut Atrophy and Maintains Intestinal Integrity in Septic Rats
- 1 March 1995
- journal article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 19 (2), 119-124
- https://doi.org/10.1177/0148607195019002119
Abstract
Background: The effects of insulin‐like growth factor‐I (IGF‐I) on gut metabolism, structure, and barrier function as well as its general anabolic effects were investigated in septic rats. Methods: Thirty‐three male Wistar rats that underwent cecal ligation were randomly divided into one of the following two groups: (1) received only total parenteral nutrition(control group) or (2) received total parenteral nutrition with IGF‐I (IGF group) at a dose of 4 mg/kg/d for 3 days. Results: During the 3‐day period, the body weight of rats in the IGF group increased significantly over that of rats in the control group (17.1 ± 2.6 vs 5.8 ± 4.6 g, p <.01). The total and free IGF‐I plasma concentrations were significantly higher in the IGF group than in the control group. The cumulative nitrogen balance was significantly more positive for the IGF group (423.9 ± 24.3 mg of nitrogen) than for the control group (290.8 ± 26.0 mg of nitrogen). The weights of thymus, spleen, and kidneys were significantly increased in the IGF group compared with weights in the control group. Treatment with IGF‐I improved the gut mucosal weight in all regions of the gut examined, including duodenum, jejunum, ileum, and colon. Histologic and biochemical analyses of the jejunum showed greater villus height and crypt depth and higher mucosal DNA and protein content in the IGF group. The arterial concentration of endotoxin was not significantly different between the two groups, whereas its level in portal blood was significantly lower in the IGF group (23.2 ± 9.9 pg/mL) than in the control group (95.5 ± 37.9 pg/mL), an indication that IGF‐I treatment decreased the amount of endotoxin that traversed the gut barrier. Conclusions: These results indicate that IGF‐I can improve gut metabolism and reduce mucosal atrophy and that it may play a role in maintaining the gut barrier function in sepsis. (Journal of Parenteral and Enteral Nutrition 19:119–124, 1995)Keywords
This publication has 29 references indexed in Scilit:
- Glutamine‐Supplemented Parenteral Nutrition Improves Gut Mucosa Integrity and Function in Endotoxemic RatsJournal of Parenteral and Enteral Nutrition, 1994
- Determination of the histological distribution of insulin like growth factor 1 receptors in the rat gut.Gut, 1993
- Effect of Glutamine‐Supplemented Total Parenteral Nutrition on Recovery of the Small Intestine After Starvation AtrophyJournal of Parenteral and Enteral Nutrition, 1993
- Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated ratsJournal of Endocrinology, 1992
- Effects of Recombinant Human Growth Hormone on Donor-site Healing in Severely Burned ChildrenAnnals of Surgery, 1990
- Gut barrier function and the surgeonBritish Journal of Surgery, 1990
- Effect of Administered Human Growth Hormone on Protein Metabolism in Septic RatsJournal of Parenteral and Enteral Nutrition, 1989
- Binding proteins for the insulin-like growth factors: Structure, regulation and functionProgress in Growth Factor Research, 1989
- POSTOPERATIVE POSITIVE NITROGEN BALANCE WITH INTRAVENOUS HYPONUTRITION AND GROWTH HORMONEThe Lancet, 1988
- Actions of Insulin-Like Growth FactorsAnnual Review of Physiology, 1985